Helmut Hero Vienna, Austria, 20180421 15:17 Posting: # 18714 Views: 5,123 

Dear all, in version 0.51 of package Power2Stage exact methods^{1,2,3} are implemented – after months of struggling (many THX to Ben). The methods are extremely flexible (arbitrary BElimits and target power, futility criteria on the PE, its CI, and the maximum total sample size, adapting for the PE of stage 1).I’ve heard in the past that regulatory statisticians in the EU prefer methods which strictly control the Type I Error (however, at the 3^{rd} GBHI conference in Amsterdam last week it was clear that methods based on simulations are perfectly fine for the FDA) and the inverse normal method with repeated confidence intervals would be the method of choice. Well roared lion; wasn’t aware of software which can to this job. That’s like saying “Fly to Mars but you are not allowed to use a rocket!” What else? Levitation? Witchcraft? Obtaining two pvalues (like in TOST) is fairly easy but to convert them into a confidence interval (as required in all guidelines) not trivial. Despite we showed this approach^{4} a while ago, nothing was published in a peerreviewed journal until very recently. Although we have a method now which demonstrated to control the TIE, I was curious how it performs in simulations (just to set it into perspective). Rcode at the end of the post (with small step sizes of CV and n_{1} expect runtimes of some hours; in large simulations I don’t recommend pmethod="exact" – about 10times slower than pmethod="nct" ). See the documentation of function power.tsd.in() about how to set futility criteria and make it fully adaptive. As usual in the latter case say goodbye to power…I explored scenarios, maximum combination test
Plots of the first four scenarios: When exploring the details it is also clear that the exact method keeps the desired power better than the simulation methods in extreme cases. Power of scenario #5 (a) and modifications:
Rcode
_{} In memory of Willi Maurer, Dr. sc. math. ETH — Cheers, Helmut Schütz The quality of responses received is directly proportional to the quality of the question asked. ☼ Science Quotes 
Helmut Hero Vienna, Austria, 20180421 18:33 @ Helmut Posting: # 18715 Views: 4,803 

Dear all, answering my own post in order to keep it short. In the following an example. We have a guesstimate of the CV (0.20), assume a GMR of 0.95, and aim at power 0.80. No futility criteria. Some regulatory statisticians told me to prefer a first stage as estimated for a fixedsample design (i.e., the second stage is solely a ‘safety net’).
In the method the weights have to be prespecified, stated in the SAP, and used throughout subsequent steps (irrespective of the reestimated n_{2}). In the fixedsample design we would need 20 subjects. How to set the weights? An intuitive way is to use the x̃ (20) of the total sample size based on simulations. This would give us weights of [1, 0]. Great. But weights have to be >0 and <1. Hence, I tweaked them a little to [0.999999, 0.000001]. What can we expect if we run the study with n_{1} 20?
Fine. If everything turns out as expected we have to be unlucky to need a second stage. Power in the first is already 0.73 and stage 2 sample sizes are not shocking. As common in TSDs the overall power is generally higher than in a fixedsample design. We perform the first stage and get GMR 0.91 and CV 0.25. Oops! Both are worse than assumed. Especially the GMR is painful.
We fail to show BE (lower CL 77.31%) and should initiate the second stage with 24 subjects. How would a ‘Type 1’ TSD perform?
Pretty similar though a lower n_{2} is suggested. OK, we perform the second stage and get GMR 0.93 and CV 0.21. Both are slightly better than what we got in the first stage but again worse than assumed.
We survived. In a ‘Type 1’ TSD we would get:
Pretty similar again. If we state it in the protocol, we could also aim for higher power in the second stage if the GMR in the first doesn’t look nice. If we switch to 0.90 we would run the second stage with 36 subjects.
Helps. Another option would be to adjust for GMR1 by using the argument usePE=TRUE in interim.tsd.in() . For power 0.80 that would mean 40 subjects in the second stage and for 0.90 already 62…— Cheers, Helmut Schütz The quality of responses received is directly proportional to the quality of the question asked. ☼ Science Quotes 
ElMaestro Hero Denmark, 20180421 18:49 @ Helmut Posting: # 18716 Views: 4,750 

Hi Hötzi, thank you for this post. What is "the inverse normal method with repeated confidence intervals" ? — if (3) 4 Best regards, ElMaestro "(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018. 
Helmut Hero Vienna, Austria, 20180421 19:41 @ ElMaestro Posting: # 18717 Views: 4,749 

Hi ElMaestro, flow chart (futility of the CI, unrestricted total sample size): Details: — Cheers, Helmut Schütz The quality of responses received is directly proportional to the quality of the question asked. ☼ Science Quotes 
mittyri Senior Russia, 20180428 13:54 (edited by mittyri on 20180428 14:08) @ Helmut Posting: # 18737 Views: 4,093 

Hi Helmut, sorry for naive questions raised from my hazelnut brain 1. I'm trying to compare the old function power.tsd(method = c("B", "C", "B0"), alpha0 = 0.05, alpha = c(0.0294, 0.0294), with a new one power.tsd.in(alpha, weight, max.comb.test = TRUE, n1, CV, targetpower = 0.8, So the old function was nice since the user can choose the method or specify 3 alphas. In the new one I see the comment regarding alpha If one element is given, the overall onesided significance level. If two elements are given, the adjusted onesided alpha levels for stage 1 and stage 2, respectively. If missing, defaults to 0.05. What about alpha0 for method C? Is it deprecated? 2. Why did you decide to include CI futility rule by default? 3. Regarding your flowchart: isn't it possible that we get some value lower than 4? power.tsd.in(CV=0.13, n1=12) for example and after first stage CV=15%, CI=[0.7991897 1.0361745]: sampleN2.TOST(CV=0.15, n1=12) 4. Is it possible to update the docs attached to the library? 5. I was confused with "2stage" 'aliased' with "tsd" and was looking for differences some time Are there any reasons to double that functions? PS: regarding 3rd point: I tried interim.tsd.in(GMR1=sqrt(0.7991897 * 1.0361745), CV1=0.15,n1=12, fCrit="No") oh, there's a default argument min.n2 = 4 OK, let's try to change that: > interim.tsd.in(GMR1=sqrt(0.7991897 * 1.0361745), CV1=0.15,n1=12, fCrit="No", min.n2 = 2) Why couldn't I select a smaller one? — Kind regards, Mittyri 
Helmut Hero Vienna, Austria, 20180428 15:29 @ mittyri Posting: # 18738 Views: 4,069 

Hi Mittyri, I’m in a hurry; so answering only part of your questions (leave the others to Detlew or Ben). » 2. Why did you decide to include CI futility rule by default? This applies only to the x.tsd.in functions (to be in accordance with the paper of Maurer et al.).» 3. Regarding your flowchart: » isn't it possible that we get some value lower than 4? » for example and after first stage CV=15%, CI=[0.7991897 1.0361745]: » sampleN2.TOST(CV=0.15, n1=12)
» Design alpha CV theta0 theta1 theta2 n1 Sample size sampleN2.TOST() is intended for the other methods where at the end stages are pooled.In the inverse normal method stages are evaluated separately (PE and MSE from ANOVAS of each stage). If you have less than 4 subjects in the second stage you will run out of steam (too low degrees of freedom). Well, 3 would work, but… » 5. I was confused with "2stage" 'aliased' with "tsd" and was looking for differences some time » Are there any reasons to double that functions? Since this is a 0.xrelease according to CRAN’s policy we can rename functions or even remove them without further notice. _{} We decided to unify the functionnames. In order not to break existing code we introduced the aliases. In the next release functions x.2stage.x() will be removed and only their counterparts x.tsd.x() kept.» regarding 3rd point: » I tried » interim.tsd.in(GMR1=sqrt(0.7991897 * 1.0361745), CV1=0.15,n1=12, fCrit="No") » […]
» oh, there's a default argument min.n2 = 4 » OK, let's try to change that: » interim.tsd.in(GMR1=sqrt(0.7991897 * 1.0361745), CV1=0.15,n1=12, fCrit="No", min.n2 = 2) » Error in interim.tsd.in(GMR1 = sqrt(0.7991897 * 1.0361745), CV1 = 0.15, : » Why couldn't I select a smaller one? See above. Doesn’t make sense with zero degrees of freedom (n_{2}=2). — Cheers, Helmut Schütz The quality of responses received is directly proportional to the quality of the question asked. ☼ Science Quotes 
d_labes Hero Berlin, Germany, 20180429 19:11 @ mittyri Posting: # 18741 Views: 4,065 

Dear Michael, just my two cents. » 1. I'm trying to compare the old function » ... » So the old function was nice since the user can choose the method or specify 3 alphas. » In the new one I see the comment regarding alpha » If one element is given, the overall onesided significance level. If two elements are given, the adjusted onesided alpha levels for stage 1 and stage 2, respectively. » If missing, defaults to 0.05. » What about alpha0 for method C? Is it deprecated? Sorry for confusion, but you definitely have to study the references (start with ^{1)}) to get a clue whats going on with this new function(s) implementing a new method for evaluating TSDs. New in the sense that it was not implemented in Power2Stage and was not applied in the evaluation of TSDs up to now. It's by no means a method adding to or amending the Potvin methods. It is a new method with a different philosophy behind. And this method, combination of pvalues of applying the TOST with the data of the two stages separately, is said to control the TIE rate at <=0.05, regardless of what design changes are done during interim, e.g. reestimation of the sample size at interim analysis. And this is not proven by simulations, but in theory, by proof. A feature which is demanded by EMA statisticians. Do you remember the statement "Potvin's methods are not valid / acceptable in Europe"? Exept Russia which is at least to some extent also in Europe IIRC... » 2. Why did you decide to include CI futility rule by default? See Helmut's answer. Maurer et al. have included a CI futility rule in their paper. And it's our behavior to set defaults according to the (first) paper(s) describing TSD evaluation methods. Ok, that may be suboptimal in comparing methods, since you always have to remember the defaults and differences within them for different functions. But, ... The recalculation or verification of results comes first. And my lazyness calls for defaults resembling the details done in the paper(s) after wich a function in Power2Stage was implemented. » 3. Regarding your flowchart: » isn't it possible that we get some value lower than 4? See Helmut's answer. Since min.n2<4 doesn't make sense it is restricted to >=4. As described in the Maurer et al. paper. » 4. Is it possible to update the docs attached to the library? Not quite clear for me what we should update. Could you please elaborate? » 5. I was confused with "2stage" 'aliased' with "tsd" and was looking for differences some time » Are there any reasons to double that functions? The real reason behind this change is lazyness of mine (sic!). It saves me 3(!) keystrokes . Believe it or not ... Don't hesitate to ask more "naive" question. We all here, including not at least me, are naive with respect to this new method of evaluating TSDs. If you feel more comfortable ask me or Helmut or Ben via the private way. I.e. write to the maintainer of Power2Stage . ^{1)} Maurer W, Jones B, Chen Y. Controlling the type 1 error rate in twostage sequential designs when testing for average bioequivalence. Stat Med. 2018;37(10):1–21. doi:10.1002/sim.7614. Drop me a Mehl if you need that sheet of paper. — Regards, Detlew 
mittyri Senior Russia, 20180430 11:41 @ d_labes Posting: # 18744 Views: 4,036 

Dear Detlew, Dear Helmut, I'm very sorry for that post, looks like I'm out of current state of TSDs... OK, I need to review the paper since certainly that's a new standard like Potvin's paper before. » » 4. Is it possible to update the docs attached to the library? » » Not quite clear for me what we should update. Could you please elaborate? I looked into Power2Stage/doc and I've found that updated on Jan2016. — Kind regards, Mittyri 
d_labes Hero Berlin, Germany, 20180425 12:19 @ Helmut Posting: # 18729 Views: 4,244 

Dear Helmut, great post. Only one remark about the weights you choose for the maximum combination test in your R code. » ...
» for (j in seq_along(CV)) { Defining the weights that way is IMHO not what you intended. Or I don't understand what you intended. It is correct if you think in terms of the standard combination test and think further that you have to specify two weights for that. But since the two weights are connected by w, 1w the second is calculated within the function power.tsd.in() automatically. You only need to define w[1] in the input argument.The idea behind the maximum combination test now is: If our first pair of weights w, 1w (chosen anyhow) is not "optimal", choose a second pair of weights w*, 1w* which is more adapted to the real situation.If you were too optimistic in your planing of n2, i.e. have chosen n2 too low compared to what really happens in the sample size adaption, it would be wise to define w* lower than w. You do that, but your choice ( w in w[1]=0.999999, w* in w[2]=1e6 ) is too extreme I think and not your intention I further think. The second pair of weights w*=1e6, 1w*=0.999999 here is for a situation were the pvalues from the second stage nearly exclusively determine the overall outcome of the maximum combination test. The pvalues from the first stage data are downweighted with w*=1e6 .Hope this sermon is not too confusing. BTW: Choosing the weights "optimal" is for me a mystery. To do that, we had to know the outcomes of the two stages, but we don't have them until the study has been done. On the other hand we have to predefine them to gain strict TIE control. Hier beißt sich die Katze in den Schwanz. — Regards, Detlew 
Helmut Hero Vienna, Austria, 20180426 07:51 @ d_labes Posting: # 18733 Views: 4,196 

Dear Detlew, » Defining the weights that way is IMHO not what you intended. OK, I see! » BTW: Choosing the weights "optimal" is for me a mystery. To do that, we had to know the outcomes of the two stages, but we don't have them until the study has been done. On the other hand we have to predefine them to gain strict TIE control. Hier beißt sich die Katze in den Schwanz. Using the median of n.tot to define the weights from the sim’s was a – maybe too naïve – attempt. Other suggestions? Some regulatory statisticians prefer the first stage in a TSD to be like in a fixed sample design. For some combinations of n_{1}/CV in my grid this will be ≤ the median of n.tot. In other words, I’m not too optimistic but rather too pessimistic. Now what? Example: CV 0.1, GMR 0.95, target power 0.80. Fixed sample design’s n 8 (n_{1} ⇒ 12 acc. to GLs). n.mean and median of n.tot 12 with the default weights (0.5, 0.25). Even the 95% percentile of n.tot is 12. — Cheers, Helmut Schütz The quality of responses received is directly proportional to the quality of the question asked. ☼ Science Quotes 
d_labes Hero Berlin, Germany, 20180426 18:02 @ Helmut Posting: # 18734 Views: 4,154 

Dear Helmut, » ... » Using the median of n.tot to define the weights from the sim’s was a – maybe too naïve – attempt. Other suggestions? Some regulatory statisticians prefer the first stage in a TSD to be like in a fixed sample design. For some combinations of n_{1}/CV in my grid this will be ≤ the median of n.tot. In other words, I’m not too optimistic but rather too pessimistic. Now what? As I already said, DUNO really. » Example: CV 0.1, GMR 0.95, target power 0.80. Fixed sample design’s n 8 (n_{1} ⇒ 12 acc. to GLs). n.mean and median of n.tot 12 with the default weights (0.5, 0.25). Even the 95% percentile of n.tot is 12. » If you were pesssimistic, so in the spirit of the MCT ist would be wise to choose the second pair of weights with decreased value. Or do I err here ("real" n2 lower than the pessimistic)? If I'm right, possible values could be: w=0.999, w*=0.5 (or something like that value) Or we stay for that extremal case with the standard combination test? But to state it again: For me it is a mystery how to choose the weights. But I think it doesn't make so much difference if we are not totally wrong with our choosen weights. As far as I have seen so far for a small number of examples: The power is influenced only to a "minor" extent. The TIE is controlled, whatsoever weights we choose. — Regards, Detlew 
d_labes Hero Berlin, Germany, 20180509 11:53 (edited by d_labes on 20180509 12:25) @ Helmut Posting: # 18757 Views: 3,772 

Dear Helmut, I have tried to demystify some aspects of choosing w and w* for the maximum combination test by looking into some examples: Take n_{fix} as sample size in stage 1 (Helmut’s proposal) Guess: CV=0.2, theta0=0.95 > n_{fix} = 20 Choose n1 = n_{fix} = 20, i.e. w= 0.99, since w has to be <1. Guess was too pessimistic: e.g. true CV=0.15 > n_{fix} = 12 or theta0=0.975 > n_{fix} = 16 For both the sample size for stage 1 exceed the necessary total sample size of a fixed design. Thus a more realistic w* can’t be defined or should be set to the same value as w. This results in the standard combination test. Guess was too optimistic: e.g. true CV=0.25 > n_{fix} = 28 or theta0=0.925 > n_{fix} = 26 Both lead to a ‘more realistic’ w*= 0.71 or 0.77. Let's choose w* = 0.7 for simplicity. Power & sample size of the scenarios
N Take n_{fix}/2 as sample size in stage 1 (Maurer et al.) Guess: CV=0.2, theta0=0.95 > n_{fix} = 20 Choose n1 = n_{fix}/2 = 10, i.e. w= 0.5. Guess was too pessimistic: e.g. true CV=0.15 > n_{fix} = 12 or theta0=0.975 > n_{fix} = 16 This would let to a ‘more realistic’ w*= 0.83 or 0.625, respectively. Let's take for simplicity w* = 0.7. Guess was too optimistic: e.g. true CV=0.25 > n_{fix} = 28 or theta0=0.925 > n_{fix} = 26 Both lead to a ‘more realistic’ w*= 0.36 or 0.38. Let's take for simplicity w* = 0.4. Power & sample size of the scenarios
N Confusion :
— Regards, Detlew 
Ben Regular 20180610 18:12 @ d_labes Posting: # 18880 Views: 3,346 

Dear All, Sorry for my rather late reply. A lot of very good comments have been made around this new function power.tsd.in . I hope there will be applications and more investigations in the future regarding this. As Detlew already mentioned: the type 1 error is controlled regardless of the scenario (we know it by theory, no simulations needed). This makes it very valuable in my opinion.I try to comment on some points made. » What about alpha0 for method C? Is it deprecated? I hope you (mittyri) had a look into the references and found some hints on it. alpha0 just does not exist in this method. For the inverse normal method we always need (only) two adjusted alpha values, one for stage 1 and another for stage 2. The fact that the function also allows you to specify only one value is for your convenience, it will then calculate the adjusted ones internally.» isn't it possible that we get some value lower than 4? It actually is never possible to get a smaller sample size. All sample size functions used in this R package give at least 4 and thus this criterion implicitly applies to all functions within Power2Stage. Comment on the weights: Detlew already pointed out some important remarks. I can only highlight again that the standard combination test for the inverse normal method already uses 2 weights, but only one (w) needs to be specified because the second is just 1w. For the maximum combination test we have 2 pairs of weights (so 4 in total), but again only the first ones of the two pairs are relevant. Those two first weights need to be spedified in the argument weight .» Some regulatory statisticians told me to prefer a first stage as estimated for a fixedsample design (i.e., the second stage is solely a ‘safety net’). Sounds interesting. At first this sounds nice, but I am a bit puzzled about it. "Safety net" sounds like we have a rather good understanding about the CV but in case we observe some unforeseen value we have the possibility to add some extra subjects. However, in such a case we could just go with a fixed design and adapt the Power. In a TSD setting we typically have no good understanding about the CV... Do I miss something here? Based on what assumptions would we select n1 (= fixed design sample size)? We typically have some range of possible values and we don't know where we will be. For n1 I would then rather use the lower end of this range. Comments? More comments on the weights: Usual practice when dealing with adaptive designs was to define not just n1 but also n2 (the theory and examples were introduced for superiority designs). One way of doing that is by calculating a fixed study design sample size and then ask yourself after what fraction we want to make a look into the data^{+}. This is done by Maurer et al and they choose 50% for the interim look. So n1 equals n2. If we assume that all subjects are evaluable this would give us a weight w of 0.5 for the first pair of weights. For superiority trials it is common practice not to go below n2 (in case the second stage is performed). Thus: if we want to apply the maximum combination test, a second weight w* being greater than w does not make sense. For the BE setting it seems this is all different. Here, n2 is flexible and can also be lower than the initially planned one. In fact, the initially planned stage 2 sample size is not really formally defined (although it theoretically exists  at least in case you calculate n1 according to some fixed design sample size). This makes the decision regarding how to define the two pairs of weights even harder. There is no unique way of defining the weights. One could for example perform some optimization procedure (with a side condition that fixes either power or sample size). Unfortunately I currently don't have an ideal solution solution to this either. _{+ Note that the intention for the interim look may be very different for superiority trials than for BE trials.} » Take n_{fix}/2 as sample size in stage 1 (Maurer et al.) » ... » Too optimistic 0.25 0.95 0.5 0.4 0.822 37.1 34 78 I can't reproduce the numbers. For ASN I get 35 and for power 0.79468. » ... » • Too pessimistic specifications result in higher power and lower expected sample size (!) (at least for CVs around 0.2) See also my comment above on the safety net. I am wondering: would we actually plan n1 such that we are (too) pessimistic? I would say: no. » • Too optimistic specifications may result in lower power and higher expected sample size (!) Brings us back to: We should plan with a realistic/slightly optimistic scenario. Best regards, Ben. 
Helmut Hero Vienna, Austria, 20180611 11:57 @ Ben Posting: # 18883 Views: 3,306 

Hi Ben, » I hope there will be applications and more investigations in the future regarding this. So do I – once we solved the mystery of finding a “suitable” n_{1} and specifying “appropriate” weights. » » Some regulatory statisticians told me to prefer a first stage as estimated for a fixedsample design (i.e., the second stage is solely a ‘safety net’). » » Sounds interesting. At first this sounds nice, but I am a bit puzzled about it. "Safety net" sounds like we have a rather good understanding about the CV … Not necessarily good but a “guesstimate”. » … but in case we observe some unforeseen value we have the possibility to add some extra subjects. » However, in such a case we could just go with a fixed design and adapt the Power. I’m not sure what you mean here. In a fixed sample design I would rather work with the upper CL of the CV or – if not available – assume a reasonably higher CV than my original guess rather than fiddling around with power. » In a TSD setting we typically have no good understanding about the CV... Do I miss something here? (1) Yep and (2) no. » Based on what assumptions would we select n1 (= fixed design sample size)? We typically have some range of possible values and we don't know where we will be. I was just quoting a regulatory statistician (don’t want to out him). Others didn’t contradict him. So likely he wasn’t alone with his point of view. » For n1 I would then rather use the lower end of this range. Comments? Very interesting. I expected that the sample size penalty (n_{2}) will be higher if we use a low n_{1}. Of course it all depends on which CV we observe in stage 1.
The pessimistic approach would be crazy. » More comments on the weights: Have to chew on that… » Brings us back to: We should plan with a realistic/slightly optimistic scenario. Seems so. — Cheers, Helmut Schütz The quality of responses received is directly proportional to the quality of the question asked. ☼ Science Quotes 
Ben Regular 20180612 17:14 @ Helmut Posting: # 18892 Views: 3,160 

Hi Helmut, » Not necessarily good but a “guesstimate”. Got it. Well... whatever a guesstimate is » » … but in case we observe some unforeseen value we have the possibility to add some extra subjects. » » However, in such a case we could just go with a fixed design and adapt the Power. » » I’m not sure what you mean here. In a fixed sample design I would rather work with the upper CL of the CV or – if not available – assume a reasonably higher CV than my original guess rather than fiddling around with power. I try to explain. In case the argument is that a TSD approach should be performed not because of an uncertain CV per se (e.g. quite a big range observed so far) but because it is desired to safeguard against an unfavorable outcome of the CV (i.e. an extreme realization / random deviate of the CV), then: stop right there. To protect against such an outcome is exactly the definition of Power (type II error) and I would question whether a TSD is really the right tool  maybe a fixed design already suffices (with a proper Power). » » In a TSD setting we typically have no good understanding about the CV... Do I miss something here? » (1) Yep and (2) no. » » Based on what assumptions would we select n1 (= fixed design sample size)? We typically have some range of possible values and we don't know where we will be. » I was just quoting a regulatory statistician (don’t want to out him). Others didn’t contradict him. So likely he wasn’t alone with his point of view. » Very interesting. I expected that the sample size penalty (n_{2}) will be higher if we use a low n_{1}. Me too. » If we base n_{1} on the lower end and the CV is close to the guesstimate that’s the winner. One the other hand there is a ~56% chance of proceeding to the second stage which is not desirable – and contradicts the concept of a “safety net”. A compromise would be 75% of the fixed sample design. » The pessimistic approach would be crazy. I agree to all of it. Best regards, Ben. 
mittyri Senior Russia, 20180611 21:27 @ Ben Posting: # 18884 Views: 3,209 

Dear Ben, Thank you for explanations! As I mentioned above, I was not aware that Maurer method is not just another set of alphas. After reading the manuscript I understood the concept. I tried to simulate some data to show the approach of safety net with inverse normal vs fixed (Helmut is right, it is very popular in Russia last days as my colleagues said; of course the Sponsors are using Potvin C ) But my loop was interrupted: interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38) What is going on here? I thought the problem with GMR1<0.9, tried to add some condition to omit the replicates with GMR1<0.9, but even that case got the same error for some replicates. — Kind regards, Mittyri 
Ben Regular 20180612 17:32 @ mittyri Posting: # 18893 Views: 3,175 

Dear mittyri, » I tried to simulate some data to show the approach of safety net with inverse normal vs fixed (Helmut is right, it is very popular in Russia last days as my colleagues said; of course the Sponsors are using Potvin C ) I hope Sponsors will be using the Inverse Normal approach in near future » But my loop was interrupted: » interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38) » Error in tval[, 1] : incorrect number of dimensions » » What is going on here? Thank you for that. Indeed, a bug. The underlying cause is the fact that the power of stage 1 is > 0.8 (in your example it is 0.8226768). That means we actually fall into the futility criterion "BE at interim not achieved and power of stage 1 is > 0.8" (this criterion was carried over from the Potvin et al decision tree). Instead of just stopping all the procedures (due to futility), interim.tsd.in proceeded and still wanted to calculate n2. This is however not possible because the estimated conditional target power is only defined if the power of stage 1 is greater than the overall power (argument targetpower ). If you still try to calculate it, you will end up with a negative estimated conditional target power which will then be put into the sample size routine as input target power  which of course will fail.I have corrected this bug on GitHub and it will be part of the next release. General remark here: In your example we see that BE has not been achieved only marginally. The Repeated CI is (0.79215, 0.99993). Even though the power of stage 1 is large enough so that we formally conclude futility, one could question whether it is really a good idea to stop the trial due to futility. On the other hand: If we want to have this futility criterion then we need a cutoff threshold, and at some point this cutoff will be met... Best regards, Ben. 
d_labes Hero Berlin, Germany, 20180613 14:59 @ Ben Posting: # 18900 Views: 3,105 

Dear Ben, » General remark here: In your example we see that BE has not been achieved only marginally. The Repeated CI is (0.79215, 0.99993). Even though the power of stage 1 is large enough so that we formally conclude futility, one could question whether it is really a good idea to stop the trial due to futility ... If I see it correctly that's called in Maurer et al. "futility rule can be applied in a nonbinding manner, ie, it can be used as guidance but must not necessarily be followed." (page 19, bottom) How to obtain a sample size number for the second stage if we want to do so? — Regards, Detlew 
Helmut Hero Vienna, Austria, 20180613 17:23 @ d_labes Posting: # 18901 Views: 3,114 

Dear Detlew, » If I see it correctly… You do. » … that's called in Maurer et al. "futility rule can be applied in a nonbinding manner, ie, it can be used as guidance but must not necessarily be followed." (page 19, bottom) Sounds to me like the statement of the FDA’s guidances “Contains Nonbinding Recommendations” or a similar one in the protocols of European Scientific Advices. » How to obtain a sample size number for the second stage if we want to do so? Introducing fuzzy logic to the AlGore Rhythm? Stop if it looks really terrible or continue if the weather is not that bad.*
— Cheers, Helmut Schütz The quality of responses received is directly proportional to the quality of the question asked. ☼ Science Quotes 
d_labes Hero Berlin, Germany, 20180614 08:18 @ Helmut Posting: # 18905 Views: 3,059 

Dear Helmut, » » How to obtain a sample size number for the second stage if we want to do so? » » Introducing fuzzy logic to the AlGore Rhythm? Stop if it looks really terrible or continue if the weather is not that bad. Let the decision to use the futility or not to NLYW ? "... there is a fundamental genderbased distinction in the functional system of this thinking apparatus: unlike male, female logic is based on fuzzy logic  wherein each statement has got several values in such a way that if women say "No", this response doesn't mean absolute 'nothingness', but implies some insensible and imperceptible features of the quite opposite response  "Yes". The same is also true for a shift in the opposite direction of evaluation in female logic  from "Yes" to "No". That is why it sometimes turns out to be a very difficult task to translate women's fuzzy logic to men's twovalued logic, that includes only "Yes" or "No", without a third value." Elmar Hussein — Regards, Detlew 
Ben Regular 20180613 18:26 @ d_labes Posting: # 18902 Views: 3,110 

Dear Detlew, » If I see it correctly that's called in Maurer et al. "futility rule can be applied in a nonbinding manner, ie, it can be used as guidance but must not necessarily be followed." (page 19, bottom) » How to obtain a sample size number for the second stage if we want to do so? The reference at page 19 actually refers to the CI futility criterion, but nevertheless the same argument should apply to the 'power of stage 1' criterion. Well, as I said: Formula (15), i.e. the formula for the estimated conditional target power is only defined if the power of stage 1, P(R_{1}), is less than the overall power 1  beta. That's a key feature of the equation. Therefore, in my opinion the only possibility is: if you want to be able to handle it in a nonbinding manner, then you have to go with conditional error rates only (i.e. you cannot use the estimated conditional target power as target power for calculation of n2). So, we would need to select ssr.conditional = "error" .Best regards, Ben. PS: Please don't shoot the messenger 
d_labes Hero Berlin, Germany, 20180614 08:47 (edited by d_labes on 20180614 08:58) @ Ben Posting: # 18906 Views: 3,079 

Dear Ben, » The reference at page 19 actually refers to the CI futility criterion, I know. » ... in my opinion the only possibility is: if you want to be able to handle it in a nonbinding manner, then you have to go with conditional error rates only (i.e. you cannot use the estimated conditional target power as target power for calculation of n2). So, we would need to select ssr.conditional = "error" .My first thought was: Set fCpower = 1 , that results in do not use the power futility criterion. This gives n2=16 for mittyri's example interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38, fCpower=1) .Your suggestion interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38, ssr.conditional = "error") gives also n2=16. Astonishing or correct? Avoiding the conditional sample size reestimation, i.e. using the conventional sample size reestimation via interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38, ssr.conditional = "no") gives n2=4. Ooops? Wow! Helmuts caveat of how to decide in case of "nonbinding futility" needs to be considered, scientifically, not via NLYW . IIRC the term "nonbinding" in the context of sequential designs is used for flexibility in stopping or continuing due to external reasons. Do we have such here? Binding, nonbinding  does it have an impact on the alpha control? I think not, but are not totally sure. — Regards, Detlew 
Ben Regular 20180615 15:58 @ d_labes Posting: # 18908 Views: 2,939 

Dear Detlew, » My first thought was: Set fCpower = 1 , that results in do not use the power futility criterion. This gives n2=16 for mittyri's example » interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38, fCpower=1) .» » Your suggestion » interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38, ssr.conditional = "error") » gives also n2=16. Astonishing or correct? This is correct. Please note that if fCpower = 1, then (as intended) the futility criterion regarding power of stage 1 never applies. If you then encounter a scenario where power of stage 1 is greater than targetpower (this must not happen, but it can happen), then the conditional estimated target power will be negative. Thus, we would have a problem with this being the target power for sample size calculation. To avoid this from happening the function automatically sets the target power for recalculation to targetpower (which is equivalent to ssr.conditional = "error"). See 'Details' in the man page.» Avoiding the conditional sample size reestimation, i.e. using the conventional sample size reestimation via » interim.tsd.in(GMR1=0.89, CV1=0.2575165, n1=38, ssr.conditional = "no") » gives n2=4. Ooops? Wow! I have to think about that » IIRC the term "nonbinding" in the context of sequential designs is used for flexibility in stopping or continuing due to external reasons. Do we have such here? For example? » Binding, nonbinding  does it have an impact on the alpha control? I think not, but are not totally sure. Nonbinding: Type 1 error is protected, even if the futility criterion is ignored. Binding: Type 1 error is protected only if the futility criterion will be adhered to. ('Binding' is not common practice, authorities don't want this). Best regards, Ben. 
d_labes Hero Berlin, Germany, 20180616 17:42 @ Ben Posting: # 18909 Views: 2,938 

Dear Ben, » » Binding, nonbinding  does it have an impact on the alpha control? I think not, but are not totally sure. » Nonbinding: Type 1 error is protected, even if the futility criterion is ignored. Was also my thought because I didn't find any relationship to a futility rule in the proof of alpha control in the paper of Maurer et al. Or do I err here? » Binding: Type 1 error is protected only if the futility criterion will be adhered to. ('Binding' is not common practice, authorities don't want this). Are you sure for the binding case? I thought: If the TIE is controlled without adhering to any futility rule, then it is more than ever controlled also by applying a futility criterion. The probability of deciding BE is lowered by doing so, and therefore also the TIE. Of course the power may be compromized. Example (some sort of 'forced BE', whatever this is): power.tsd.in(CV=0.25, theta0=0.9, GMR=0.9, n1=36) gives pBE('empiric power')= 0.68452 (!). Increasing n1 doesn't help. Try it. Empiric TIE (theta0=1.25) is: pBE= 0.034186. Without the futility criterion w.r.t. the CI power.tsd.in(CV=0.25, theta0=0.9, GMR=0.9, n1=36, fCrit="no") you obtain pBE('empiric power')= 0.80815. Power much more raised if you also forget the power futility rule: power.tsd.in(CV=0.25, theta0=0.9, GMR=0.9, n1=36, fCrit="no", fCpower=1) gives a pBE= 0.90658. Empiric TIE (theta0=1.25) is: pBE= 0.050012. Nitpickers! Don't cry "alpha inflation"! The +0.000012 to 0.05 is the simulation error. Try setseed=F and you will get something like p(BE)= 0.049858 or in the next run p(BE)= 0.04982.I think that your statement for the binding case is only valid if you make a further adaption of the local alpha / critical values taking the futility rule into consideration. But I don't know how this could be done. The implementation in Power2Stage anyhow doesn't make such an adaption, if I see it correctly. Do you have any experinces for your statement 'Binding' is not common practice, authorities don't want this'. If yes, what is/are the reason(s) given by authorities to abandon binding futility rule(s) or not to 'like' them? — Regards, Detlew 